Literature DB >> 3004547

Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer.

D J Horsfall, W D Tilley, S R Orell, V R Marshall, E L Cant.   

Abstract

The relationship between ploidy, as measured by flow cytometry, and the presence of oestrogen and progesterone receptors was investigated in 145 primary invasive breast cancers. The tumours were considered as an integral group, and as subgroups of lobular and ductal carcinomas. An association was found between the presence of aneuploid stemlines and an absence of oestrogen receptors (ER), for the total tumour population (P less than 0.02), and for the ductal carcinoma group (P less than 0.05). An association between aneuploidy and an absence of progesterone receptors (PR) was observed for the total tumour group (P less than 0.05). Evaluation of a combined oestrogen and progesterone receptor status indicated that the association between aneuploidy and an absence of both receptors was highly significant. The probability of such an association was P less than 0.001 for the total tumour population, and P less than 0.01 for the ductal tumour group. Assessment of progesterone receptor expression by breast cancers containing oestrogen receptors indicated that aneuploid tumours were as likely to express PR as were diploid tumours. Hence, the biological activity of oestrogen receptors appears unmodified by the presence of aneuploid nuclei.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004547      PMCID: PMC2001456          DOI: 10.1038/bjc.1986.4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  An evaluation of DNA fluorochromes, staining techniques, and analysis for flow cytometry. I. Unperturbed cell populations.

Authors:  I W Taylor; B K Milthorpe
Journal:  J Histochem Cytochem       Date:  1980-11       Impact factor: 2.479

Review 2.  Oestrogen receptors and breast cancer: current status.

Authors:  R A Hawkins; M M Roberts; A P Forrest
Journal:  Br J Surg       Date:  1980-03       Impact factor: 6.939

3.  Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.

Authors:  G Auer; E Eriksson; E Azavedo; T Caspersson; A Wallgren
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

4.  Primary cultures of estrogen-responsive cells from rat uteri: induction of progesterone receptors and a secreted protein.

Authors:  J A Kassis; D Sakai; J H Walent; J Gorski
Journal:  Endocrinology       Date:  1984-05       Impact factor: 4.736

5.  The influence of age on the DNA ploidy levels of breast tumours.

Authors:  I W Taylor; E A Musgrove; M L Friedlander; M S Foo; D W Hedley
Journal:  Eur J Cancer Clin Oncol       Date:  1983-05

6.  Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.

Authors:  G U Auer; T O Caspersson; S A Gustafsson; S A Humla; B M Ljung; B A Nordenskjöld; C Silfverswärd; A S Wallgren
Journal:  Anal Quant Cytol       Date:  1980-12

7.  Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.

Authors:  T E Kute; H B Muss; D Anderson; K Crumb; B Miller; D Burns; L A Dube
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

Review 8.  Oestrogen receptors in human breast cancer: review of histopathological correlations and critique of histochemical methods.

Authors:  J C Underwood
Journal:  Diagn Histopathol       Date:  1983 Jan-Mar

9.  The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.

Authors:  J M Howat; D M Barnes; M Harris; R Swindell
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

10.  Inter-site variation of oestrogen receptors in human breast cancers.

Authors:  W D Tilley; D D Keightley; E L Cant
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

View more
  13 in total

1.  Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.

Authors:  P G Gill; W D Tilley; N J De Young; I L Lensink; P D Dixon; D J Horsfall
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

2.  Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas.

Authors:  C L Arteaga; M D Johnson; G Todderud; R J Coffey; G Carpenter; D L Page
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.

Authors:  T Yokoe; M Izuo; T Ishida; Y Iino; T Kawai
Journal:  Jpn J Surg       Date:  1990-09

4.  Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.

Authors:  J Harvey; N de Klerk; I Berryman; G Sterrett; M Byrne; J Papadimitriou
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

5.  Sequential determination of immunocytochemical estrogen receptor and nuclear DNA content in fine needle biopsies from breast carcinoma.

Authors:  C B Pestana; N Donozo; A J Pinto; P C de Almeida; G M Machado-Santelli
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

6.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Epidermal growth factor receptor in breast cancer: storage conditions affecting measurement, and relationship to steroid receptors.

Authors:  W R McLeay; D J Horsfall; R Seshadri; D A Morrison; G T Saccone
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.

Authors:  C R Wenger; S Beardslee; M A Owens; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

9.  Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.

Authors:  S Toikkanen; E Eerola; T O Ekfors
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

10.  Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma.

Authors:  G Gasparini; S Dal Fior; F Pozza; P Bevilacqua
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.